•  
  •  
  •  
  •  

2026-04-21 21:54:19

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • CMPDI Reports ₹2,316 Crore Revenue for FY26; Annual Profit Stands at ₹613 Crore
  • Purple Finance Reports Strong Q4 FY26 Performance, Sustains Profitability and Accelerates Growth Momentum
  • Sunteck Realty Limited recommends final dividend of Rs. 1.50
  • Rajratan Global Wire Ltd recommends final dividend of Rs. 2
  • PNC Infratech Ltd emerges L1 for NHAI tenders for 2 HAM Projects

Keywords Selected:  SLA

Research

  • 82% of professionals are concerned about job redundancy due to emerging technologies: Hero Vired Report
  • Dr. Reddy's Laboratories - Analyst Meet Update - Multiple growth initiatives - BUY
  • Q4FY22 Result Update – Laurus Labs - ICICI Direct

Stock Report

  • Intellect announces purpose-built end-to-end Islamic Banking functionality with eMACH.ai Islamic Banking
  • Lupin Launches Dapagliflozin Tablets in the United States
  • Dr. Reddy's Laboratories announces launch of India's first DCGI-approved Semaglutide injection 'Obeda®' for Type 2 Diabetes
  • RNIT AI Solutions Ltd inks SLA with Commissionerate of Higher Education, Government of Andhra Pradesh
  • Axis Bank becomes preferred financer for Tesla to enable seamless EV financing across India
  • Godrej Properties Wins Bid for a ~ 5-Acre Land Parcel off EM Bypass, Kolkata
  • Dr. Reddy's forays into Hormone Replacement Therapy segment with acquisition of Progynova® and Cyclo- Progynova® in India
  • Spice Islands Industries Limited announces entry into Global Trade with First Export Order from UAE
  • Laurus Labs Ltd reports consolidated net profit of Rs. 251.66 crores in Q3 FY2026
  • Dr Reddys Laboratories Ltd consolidated Q3 FY2025-26 PAT drops to Rs. 1209.8 crores
  • Bartronics India signs long-term SLA to scale Maharashtra Gramin Bank's rural banking network
  • Verso Altima India Pvt Ltd launches new products
  • Dr. Reddy's Laboratories announces Science-Based Net Zero Climate Targets
  • Senores Pharmaceuticals, Inc. announces the approval and launch of Deferiprone Tablets USP, 500 mg & 1000 mg
  • Immutep and Dr. Reddy's Enter Strategic Collaboration for Commercialisation of an Innovative Oncology Drug, Eftilagimod Alfa
  • Veefin Wins Supply Chain Finance Mandate from Bank of the Philippine Islands for Philippines Deployment
  • Dr. Reddy's receives European Commission Approval for AVT03 (denosumab), a Proposed Biosimilar of Prolia® and Xgeva®
  • USFDA inspects Unit 1 of Divi's Laboratories Limited
  • Shriram Properties signs another JDA for 5 acre Land in Bannerghatta to Develop Premium Villaments
  • Dr Reddys Laboratories Ltd reports Rs. 1437.2 crores consolidated PAT in Q2FY26
  • Laurus Labs Limited approves interim dividend of Rs. 0.80
  • Laurus Labs Ltd reports rise in Q2FY26 consolidated PAT to Rs. 194.97 crores
  • TCS Conducts the World's Largest AI Hackathon
  • Jindal Stainless doubles slag processing capacity, advancing circular production and natural resources conservation

Union Budget

  • Income Tax Slab, Rates Changes Expected in Budget: Will Basic Exemption Limit of Rs 2.5 lakh Increase?

Latest Post

  • CMPDI Reports ₹2,316 Crore Revenue for FY26; Annual Profit Stands at ₹613 Crore
  • Purple Finance Reports Strong Q4 FY26 Performance, Sustains Profitability and Accelerates Growth Momentum
  • Sunteck Realty Limited recommends final dividend of Rs. 1.50
  • Rajratan Global Wire Ltd recommends final dividend of Rs. 2
  • PNC Infratech Ltd emerges L1 for NHAI tenders for 2 HAM Projects


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025